🇺🇸 PTGX — Protagonist Therapeutics, Inc.

Salud Compra fuerte
← Volver

Precio actual

135,26 USD

Máx. histórico

158,62

80 días

Caída desde máximo

-14,73%

Rango 52 semanas

76,70 – 160,81

Variación hoy

-5,66%

Cierre anterior

143,37

Rango de hoy

134,39 – 143,30

Volumen hoy

582.605

Peor caída histórica

-85,79%

01/09/2021 → 13/06/2022

Recuperado en 1001 días

Volatilidad anualizada ⓘ

89,33%

Información
Nombre completo
Protagonist Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGM
Sector
Salud
Industria
Biotechnology
Empleados
141
PER ⓘ
131,32 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
178,57 USD (puede no estar actualizado)
Primera cotización
11/08/2016
Precio actualizado
hace 7 horas
Sobre la empresa

Protagonist Therapeutics, Inc. operates as a discovery and development company in the United States. It develops Icotyde, a first-in-class investigational targeted oral peptide for the treatment of adults and pediatric patients 12 years of age and older with moderate-to-severe plaque psoriasis; and Rusfertide, a first-in-class investigational injectable mimetic of the natural hormone hepcidin in Phase 3 development for the treatment of the rare blood disorder polycythemia vera. The company is also developing PN-881, a potential best-in-class oral peptide IL-17 antagonist, for the treatment of immune-mediated skin diseases in Phase 1 clinical trials; PN-477 and PN-458, which are development candidates for the treatment of obesity; PN-8047, an orally administered hepcidin functional mimetic small molecule; L-4R alpha antagonist for the treatment of atopic dermatitis and moderate-to-severe asthma; and amylinR-based oral and subcutaneous mono- and poly-agonists for the treatment of obesity. Protagonist Therapeutics, Inc. was incorporated in 2006 and is headquartered in Newark, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
22/02/2023 15,83 16,25 15,72 15,81 +0,44% 3,35% 687.500
21/02/2023 15,90 16,38 15,53 15,74 -2,66% 5,37% 779.400
17/02/2023 15,62 16,25 15,47 16,17 +3,65% 4,99% 727.100
16/02/2023 16,02 16,15 15,47 15,60 -4,41% 4,24% 680.600
15/02/2023 15,67 16,40 15,43 16,32 +3,16% 6,19% 933.700
14/02/2023 15,92 16,28 15,69 15,82 -1,37% 3,71% 1.225.400
13/02/2023 17,18 17,37 15,93 16,04 -6,80% 8,35% 1.158.300
10/02/2023 16,88 17,28 16,60 17,21 +1,12% 4,03% 1.338.300
09/02/2023 16,77 17,97 16,75 17,02 +2,72% 7,27% 2.193.400
08/02/2023 15,83 16,85 15,64 16,57 +4,67% 7,64% 2.006.000
07/02/2023 14,96 15,93 14,93 15,83 +5,82% 6,68% 1.410.800
06/02/2023 14,26 15,02 14,10 14,96 +4,40% 6,42% 932.600
03/02/2023 14,26 14,63 14,25 14,33 -0,90% 2,66% 647.900
02/02/2023 14,23 14,76 14,04 14,46 +2,84% 5,02% 1.550.000
01/02/2023 13,28 14,28 13,18 14,06 +5,79% 8,28% 1.067.000
31/01/2023 13,08 13,61 12,91 13,29 +2,31% 5,35% 1.250.100
30/01/2023 13,33 13,46 12,80 12,99 -3,71% 4,95% 878.800
27/01/2023 13,16 13,89 12,81 13,49 +2,35% 8,21% 966.400
26/01/2023 13,16 13,37 12,87 13,18 +0,23% 3,76% 708.500
25/01/2023 12,49 13,38 12,22 13,15 +3,54% 9,23% 1.414.200
24/01/2023 11,47 12,78 11,21 12,70 +10,72% 13,69% 2.044.800
23/01/2023 11,68 11,79 11,31 11,47 -1,63% 4,11% 565.100
20/01/2023 11,94 12,04 11,43 11,66 -1,44% 5,11% 748.900
19/01/2023 11,80 12,22 11,64 11,83 -0,25% 4,87% 677.800
18/01/2023 11,85 12,32 11,59 11,86 +1,80% 6,16% 1.197.300
17/01/2023 12,18 12,28 11,57 11,65 -4,27% 5,79% 817.500
13/01/2023 12,59 12,78 11,97 12,17 -4,55% 6,47% 1.207.900
12/01/2023 12,14 13,11 12,12 12,75 +5,72% 8,15% 1.174.200
11/01/2023 11,74 12,14 11,40 12,06 +2,55% 6,30% 722.000
10/01/2023 11,28 11,79 11,21 11,76 +3,70% 5,14% 677.800